You are here:

Archived: Escitalopram (Cipralex®)

Advice

Not recommended for use in NHS Scotland.

RECOMMENDATIONS

While escitalopram has been shown to be as effective as citalopram in short-term use, longer-term data are limited and do not address issues such as relapse, remission and withdrawal/rebound phenomena. No clear benefits are demonstrated over the parent product- citalopram.

The license holder has indicated their decision to resubmit in light of additional information now being available.

Drug Details

Drug Name: Escitalopram (Cipralex®)
SMC Drug ID: 17/02
Manufacturer: Lundbeck Ltd
Indication: Major depressive episodes
BNF Category:
Sub Category: 4.3 Antidepressant drugs
Submission Type: Full submission
Status: Not Recommended
Date Advice Published: 8 November 2002

Current Advice

Resubmission 7 March 2003

Back